German Ott
Impact in
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 365
- Genetic factors in colorectal cancer 33
- Genetics 132
- Chronic Lymphocytic Leukemia Research 123
- Co-authors
- Andreas Rosenwald (131 shared papers)Hans Konrad Müller‐Hermelink (48 shared papers)Elı́as Campo (49 shared papers)Tiemo Katzenberger (38 shared papers)Jörg Kalla (34 shared papers)Michaela Ott (26 shared papers)Randy D. Gascoyne (26 shared papers)Maria Michaela Ott (19 shared papers)
- Journals
- Blood (93 papers)Leukemia (30 papers)Nature Communications (18 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (18 papers)Haematologica (18 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
German Ott
511 papers receiving 57.1k citations
German Ott's Hit Papers
Peers
Comparison fields: 5 of 181
- Pathology and Forensic Medicine 32.2k
- Genetics 15.3k
- Oncology 21.1k
- Cancer Research 9.2k
- Immunology 8.4k
Countries citing papers authored by German Ott
This map shows the geographic impact of German Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by German Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites German Ott more than expected).
Fields of papers citing papers by German Ott
This network shows the impact of papers produced by German Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by German Ott. The network helps show where German Ott may publish in the future.
Co-authors
The 25 scholars most cited alongside German Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 519 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma Hit paper breakdown → | 2002 | 3164 |
| 2 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms Hit paper breakdown → | 2022 | 2560 |
| 3 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 4 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Hit paper breakdown → | 2022 | 2312 |
| 5 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 6 | Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma Hit paper breakdown → | 2018 | 1669 |
| 7 | Stromal Gene Signatures in Large-B-Cell Lymphomas Hit paper breakdown → | 2008 | 1464 |
| 8 | Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes Hit paper breakdown → | 2018 | 1441 |
| 9 | Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma Hit paper breakdown → | 2010 | 1365 |
| 10 | Oncogenically active MYD88 mutations in human lymphoma Hit paper breakdown → | 2010 | 1238 |
| 11 | Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells Hit paper breakdown → | 2004 | 1136 |
| 12 | Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma Hit paper breakdown → | 2003 | 882 |
| 13 | Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Hit paper breakdown → | 2012 | 806 |
| 14 | Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways Hit paper breakdown → | 2008 | 802 |
| 15 | A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling Hit paper breakdown → | 2006 | 791 |
| 16 | The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma Hit paper breakdown → | 2003 | 736 |
| 17 | Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2008 | 726 |
| 18 | Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics Hit paper breakdown → | 2012 | 707 |
| 19 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 20 | Molecular Diagnosis of Burkitt's Lymphoma Hit paper breakdown → | 2006 | 690 |
About German Ott
German Ott is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Cancer Research and Immunology, having authored 519 papers that have together received 58.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (365 papers), Chronic Lymphocytic Leukemia Research (123 papers), Viral-associated cancers and disorders (121 papers), Cancer Genomics and Diagnostics (40 papers), CAR-T cell therapy research (36 papers), Immune Cell Function and Interaction (33 papers), Genetic factors in colorectal cancer (33 papers) and CNS Lymphoma Diagnosis and Treatment (32 papers). The work is most often cited by research in Pathology and Forensic Medicine (32.2k citations), Genetics (15.3k citations), Oncology (21.1k citations), Cancer Research (9.2k citations) and Immunology (8.4k citations). German Ott has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Andreas Rosenwald, Hans Konrad Müller‐Hermelink, Elı́as Campo, Tiemo Katzenberger, Jörg Kalla, Michaela Ott, Randy D. Gascoyne, Maria Michaela Ott, Elena Gerhard-Hartmann and Thomas Rüdiger. Their work appears in journals such as Blood, Leukemia, Nature Communications, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.